Bioethics Panels Open Door Slightly to Germline Gene Editing
By Jeff Lyon,
JAMA
| 10. 18. 2017
As CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats–Cas9) and other gene-editing technologies hasten the feasibility of effective somatic and germline genomic manipulation, an international panel of genetics groups has weighed in on some of the thorniest ethical and scientific implications facing clinical use of gene editing.
Led by the American Society of Human Genetics (ASHG), 11 organizations published a joint statement in August concentrating on the prospects for germline alteration, a no-fly zone among molecular biologists since the dawn of gene therapy in the 1980s. The ASHG-sponsored statement was drafted by a committee of representatives from the UK Association of Genetic Nurses and Counsellors, Canadian Association of Genetic Counsellors, the International Genetic Epidemiological Society, and the US National Society of Genetic Counselors, as well as the ASHG. The final document was endorsed by these groups and 6 other international medical or genetics associations.
The new statement does not rule out the eventual therapeutic editing of human DNA in ways that could be passed along to later generations: “Currently, there is no reason to prohibit in vitro germline genome editing on...
Related Articles
By Margaret R. Eby, Los Angeles Review of Books | 03.15.2026
IN MARCH 2017, then–vice president Mike Pence tweeted a photo of himself at a table with members of the House Freedom Caucus discussing plans to repeal the Affordable Care Act (ACA) and replace it with the American Health Care Act...
By Michael Levenson, The New York Times | 02.27.2026
The pharmaceutical giant Novartis has reached a settlement with the family of Henrietta Lacks, a Black woman whose cells were taken from her without her consent in 1951, when she was dying of cervical cancer in a segregated ward at...
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...
